What I see is a pinksheet stock and Rule 504D in conjunction with recent SEC filings
Once I see the ethical obligation to the medical community to register the study, the WAT will have been proved incorrect. That's it. No need for insulting comments
the above is all IMHO (consider this my safe harbor statement)